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Predictors of loss to follow up among
patients with type 2 diabetes mellitus
attending a private not for profit urban
diabetes clinic in Uganda – a descriptive
retrospective study
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Rose Nabwato1, Aisha Kigongo1, Edward Ddumba2, Billy N. Mayanja1, Pontiano Kaleebu1,3, Rob Newton1,4 and
Moffat Nyerinda1,3
Abstract
Background: Although the prevalence of type 2 diabetes mellitus is increasing in Uganda, data on loss to follow
up (LTFU) of patients in care is scanty. We aimed to estimate proportions of patients LTFU and document
associated factors among patients attending a private not for profit urban diabetes clinic in Uganda.
Methods: We conducted a descriptive retrospective study between March and May 2017. We reviewed 1818 out-
patient medical records of adults diagnosed with type 2 diabetes mellitus registered between July 2003 and
September 2016 at St. Francis Hospital - Nsambya Diabetes clinic in Uganda. Data was extracted on: patients’
registration dates, demographics, socioeconomic status, smoking, glycaemic control, type of treatment, diabetes
mellitus complications and last follow-up clinic visit. LTFU was defined as missing collecting medication for six
months or more from the date of last clinic visit, excluding situations of death or referral to another clinic. We used
Kaplan-Meier technique to estimate time to defaulting medical care after initial registration, log-rank test to test the
significance of observed differences between groups. Cox proportional hazards regression model was used to
determine predictors of patients’ LTFU rates in hazard ratios (HRs).
Results: Between July 2003 and September 2016, one thousand eight hundred eighteen patients with type 2
diabetes mellitus were followed for 4847.1 person-years. Majority of patients were female 1066/1818 (59%) and
1317/1818 (72%) had poor glycaemic control. Over the 13 years, 1690/1818 (93%) patients were LTFU, giving a LTFU
rate of 34.9 patients per 100 person-years (95%CI: 33.2–36.6). LTFU was significantly higher among males, younger
patients (< 45 years), smokers, patients on dual therapy, lower socioeconomic status, and those with diabetes
complications like neuropathy and nephropathy.
Conclusion: We found high proportions of patients LTFU in this diabetes clinic which warrants intervention studies
targeting the identified risk factors and strengthening follow up of patients.
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Background
Globally, 422 million adults aged over 18 years were living
with diabetes mellitus in 2014 and this is expected to rise
to 552 million by 2030 [1]. Type 2 diabetes mellitus is be-
coming epidemic in nearly every population and it’s pro-
posed that without effective prevention and control
programmes, the prevalence will continue to increase glo-
bally most likely as a result of rising overweight and obes-
ity rates, lifestyle, dietary changes, and an ageing
population [2]. This condition is not only affecting devel-
oped countries but it’s rising rapidly in low and middle in-
come countries [3, 4]. However, the health systems in low
and middle income countries have mainly targeted health-
care provision for acute episodic conditions and not med-
ical care for chronic conditions. In Uganda the prevalence
of diabetes mellitus is estimated at 10.1% while impaired
glucose tolerance is estimated at 13.8% [5].
Several studies conducted in developed countries have
shown that continuous care and greater compliance to
clinic appointments is associated with good glycaemic con-
trol, decreased probability of diabetes-related complications
and mortality because patients who stop treatment miss op-
portunities for detecting complications and treatment ad-
justments [6–11]. However, in other developed countries
the rates of patients dropping out from diabetes care are
high and varied: 5.4 and 18% in Malaysia [12], 5.5% in Ger-
man [13], 12% in Nashville-Tennessee [14] and 46% in
Canada [15]. Quantitative studies done in the United King-
dom and United States showed that overweight or obesity,
hypertension, presence of neuropathy, poor glycaemic con-
trol, older age, low income, smoking, rural residence and
male sex were associated with clinic follow-up non-attend-
ance [14, 16–21]. Another study revealed that men, not be-
ing on insulin or antiplatelet agents, having higher HbA1c,
higher Low Density Lipoprotein Cholesterol (LDL-C) and
having complications of diabetes mellitus were associated
with follow-up non-attendance. Older age and higher LDL-
C were also associated with higher mortality. Reports from
Africa on LTFU are limited, but one study conducted in
Kenya reported a dropout rate of 31% among registered pa-
tients with diabetes mellitus in a primary health care pro-
gram [22]. In a recent systematic review of factors affecting
follow-up non-attendance, 83 factors were classified into
three categories. These included patient factors (e.g. mental
state, alcohol and tobacco use, etc.); disease and medication
factors (e.g. poor disease control); and health care provider
factors (e.g. scheduling, health provider characteristics, doc-
tor-patient relationships [23]. In Uganda, no study has esti-
mated the LTFU among patients with diabetes mellitus and
we theorize that rates of LTFU are high and its predictors
are varied. Therefore, this descriptive retrospective study of
clinic medical records through chart reviews was under-
taken to estimate the LTFU rates and document the associ-
ated factors since this is an important determinant of poor
glycaemic control long-term outcomes. The findings from
this study will inform policy makers and program managers
to address the challenges of patient LTFU as well as provide
a base line report for interventions aimed at reducing LTFU
in the management of diabetes mellitus.
Methods
Study design, setting and population
This was a descriptive retrospective study of 1818 selected
medical records of adult patients with diabetes mellitus who
were registered in the diabetes clinic at St. Francis Hos-
pital Nsambya in Kampala-Uganda, which is a private not
for profit facility [24]. The hospital conducts a diabetes melli-
tus clinic that operates once a week serving an average of 60
patients on each clinic day. In the diabetes clinic, all patients
receive diabetes mellitus health education offered by trained
diabetes nurses and fasting blood glucose measurements
prior to being reviewed by the doctors [25]. The study popu-
lation comprised of patients with type two diabetes mellitus
who were registered at the clinic between July 2003 and Sep-
tember 2016. The charts were reviewed by a medical doctor,
clinical officer and registered nurses for sociodemographic
characteristics, date of registration, date of last clinic visit and
clinical outcomes using a data collection guide. Patients
whose paper clinic records files could not be located, those
with missing information, transferred out or recorded as
dead, type 1 diabetes mellitus, gestational diabetes were
excluded.
Definition of variables
LTFU: Patients were considered LTFU if they had missed
collecting medication for six or more consecutive months
from the date they last visited the clinic and retention in
medical care considered as continuous follow-up visits to
the same health-care service to seek treatment for the
same episode of illness [26]. Transfer to other facilities or
death of a patient were not regarded as LTFU.
Different treatment options were defined as follows:
Life style alone was defined as non-pharmacological
treatment involving changes in diet and increased exer-
cise; monotherapy as use of metformin alone or any
other single oral hypoglycemic; dual therapy as a com-
bination of metformin plus another oral hypoglycemic
or metformin plus insulin; triple therapy as a combin-
ation of metformin plus two other oral hypoglycemic
agents or metformin plus another oral hypoglycemic and
insulin; and combination injection therapy was defined
as use of different insulin regimens.
Hypertension: This was defined as systolic blood pres-
sure ≥ 140 mmHg and/or diastolic pressure of ≥90
mmHg.
Optimal glycaemic control: This was defined as pre-
prandial glucose 4.4–7.2 mmol/L measured as an average
of the last 3 readings on 3 separate clinic visits among
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patients with diabetes mellitus under care. Fasting glu-
cose reading of > 7.2 mmol/L was considered as uncon-
trolled glycaemia.
Socioeconomic status (SES) was defined based on
house hold assets. Upper SES defined as living in a
house with electricity or solar power supply, piped water,
flushing toilet and kitchen inside; Middle SES as living
in a house with at least one but not all the utilities
above; Lower SES as living in a house without the above
and not mud or wattle and not grass hatched; Poor SES
as living in mud and wattle grass hatched house and
none of the amenities above.
For residence we used the host hospital's definations;
urban was defined as living within 1 km (km) of a town
council; Peri-urban as living within 1 km of a shop sell-
ing soft drinks and Rural as living more than 1 km of a
shop selling soft drinks.
Data source and collection
The data for this research was secondary data collected
routinely in the hospital for patients’ clinical monitoring
and evaluation purposes. Data was collected and entered
into a Microsoft Excel 2010 database (Microsoft Corp.,
Redmond, WA), checked for consistencies and complete-
ness, and then exported to STATA 13.1 (Stata Corp, Col-
lege Station, TX, USA) for further management and
analysis. Data collected for this review included demo-
graphics, date of first registration, date of last clinic visit,
past medical history, glycaemic levels, medication use,
complications of diabetes and biophysical measurements.
The primary outcome variable was LTFU from the dia-
betes mellitus care after initiation of treatment, confirmed
by reviewing medical records at the hospital.
Statistical analysis
The patients’ characteristics were described in terms of
mean, median or percentage as appropriate. The
Kaplan-Meier technique was used to estimate time to
defaulting medical care after initial registration into the
diabetes clinic, while the log-rank test was used to test
the significance of observed differences between groups.
The Cox proportional hazards regression model was
used to determine predictors of patients’ retention and
defaulting rates expressed as estimated hazard ratios
(HRs) with their corresponding 95% confidence intervals
(CIs). At the unadjusted modelling level, variables which
gave a Log- Likelihood ratio tests (LRTs) p-value less
than or equal to 0.1 were considered for the adjusted
model. At the multivariable analysis, variables that were
earlier dropped, were again added onto the model one
by one to look at the effect until the final model was ob-
tained. Variables whose p-value was less than 0.05 level
were considered to be independent risk factors of LTFU
in this study. We considered age and sex as priori
confounders.
Results
Between July 2003 and September 2016, a total of 2518 dia-
betes mellitus patients were registered in the diabetes clinic
of St. Francis Hospital Nsambya in Kampala, Uganda. We
excluded 700 records due to missing files, files with missing
information, type 1 diabetes mellitus, gestational diabetes
mellitus, deaths and transfers out (Fig. 1). The 1818 patients
included in the study were followed for a total of 4847.1 per-
son-years, with the longest individual follow up being 14.2
years. The majority of the patients were females 59% (n=
1066), 75% were aged more than 45 years old (n= 1364),
89% resided in peri-urban and urban areas (n= 1611), 76%
belonged to middle and upper social class (n= 1328), about
10% were smokers (n= 190), 26% were alcohol consumers
(n= 466), 18% had retinopathy (n= 330), 66% had uncon-
trolled hypertention (n= 1199) and 72% (n= 1317) had poor
glycaemic control (Table 1).
Over the 13 years follow up, 93% (n = 1690) of the pa-
tients were lost to follow up, with 52% (n = 945) of the
LTFU occurring within the first year after registration in
the diabetes clinic. The median time to LTFU was 11
months; Interquartile range 5.9 to 45.0 months. The esti-
mated LTFU rate was 34.9 per 100 person-years (95%
CI: 33.2 – 36.6). In the multivariate analysis, male pa-
tients were more likely to be LTFU than females (ad-
justed Hazard Ratio, aHR 1.17 [95% CI: 1.06–1.30]).
Patients aged 45–64 years (aHR 0.83; 95% CI: 0.74–0.94)
and those above 64 years (aHR 0.78; 95% CI: 0.67–0.90)
were more likely to be retained in care than the younger
age group of 44 years and below. Retention in diabetes
mellitus care was also associated with middle socioeco-
nomic status (aHR 0.83; 95% CI: 0.74–0.94) and upper
social economic status (aHR 0.83; 95% CI: 0.73–0.95)
compared to lower socioeconomic status, being a non-
smoker (aHR 0.82; 95% CI: 0.70–0.96) and being on dual
therapy (aHR 0.78; 95% CI: 0.70–0.86). Loss to follow up
from care was associated with diabetes mellitus compli-
cations such as neuropathy (aHR 1.38; 95% CI: 1.24–
1.54), nephropathy (aHR 1.76; 95% CI: 1.41–2.20), being
on triple therapy (aHR of 1.30; 95% CI: 1.03–1.63). Pa-
tients on lifestyle control alone and combination injec-
tion therapy were few and were not associated with loss
to follow up. Residence, education level, alcohol intake,
lifestyle therapy alone, combination injection therapy,
complications of diabetes mellitus such as hypertension,
retinopathy, macroangiopathy (coronary artery disease,
cerebral vascular disease, peripheral vascular disease),
diabetic foot, having hypoglycaemic episodes and uncon-
trolled glycaemia were not independently associated with
LTFU (Table 2).
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Discussion
In this retrospective study, we found a high proportion of
loss to follow up among patients with diabetes mellitus at-
tending a diabetes clinic in a private not for profit urban hos-
pital in Uganda. We found that male gender, having diabetic
complications such as neuropathy and nephropathy, and
using a triple therapy regimen significantly associated with
LTFU. Retention in diabetes care was associated with older
age, being in middle and upper socioeconomic status, being
a non-smoker and being on a dual therapy regimen. We also
found high rates of hypertension and a large number of pa-
tients did not achieve the recommended targets for optimal
diabetes control.
Our LTFU proportion was much higher than that reported
from developed countries which varied from 5.4 to18% in
Malaysia, 5.5% in German [13], 12% in Nashville-Tennessee
[14] and 46% in Canada [15]. Similarly, our LTFU proportion
was higher than that reported from Kenya which had a drop-
out rate of 31% [22]. Our study was done in a private not for
profit hospital where patients pay for their care and that
could explain the high proportion of patients lost to follow
up. Although the LTFU might be due to deaths being mis-
classified as LTFU the cost of medical care could have re-
sulted in the majority of patients with diabetes mellitus self-
refering themselves to other public facilicties where care is
free, without proper referral procedures. This is supported
by the findings that those with middle and higher socioeco-
nomic status and thus more able to meet the medical care
costs were more likely to be retained compared to the lower
socioecomic status. However since deaths and transfer outs
were not recorded, the resultant misclassification might have
led to a biased high estimate of the LTFU as high mortality
rates among diabetes patients have previously been reported
from some studies [27–29].
In our study, we found that male gender, was associ-
ated with loss to follow up, similar findings were re-
ported by Chew et al. who analysed the diabetes
mellitus registry in Malaysia [12]. Other chronic care
treatment providers like HIV programs have also re-
ported that males were associated with clinic non-at-
tendance. Additionally, being on a triple therapy
regimen and having had complications of diabetes melli-
tus like neuropathies and nephropathy were also associ-
ated with loss to follow up. However, if the patients with
diabetes complications and those on triple therapy could
have died, this could have possibly lead to a biased
overestimate of LTFU. These findings are similar to
those that were reported by Chew et al., in Malaysia
and similar to other quantitative studies done in the
United Kingdom and United States that showed
Fig. 1 Study organogram
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Table 1 Baseline characteristics of patients retained and LTFU in a retrospective chart review study of patients with type 2 diabetes
mellitus
Variable Name Category Retained N (col %) 128 (7%) LTFU N (col %) 1690 (93%) Chi-Square P-value
Socio-demographic characteristics
Sex 0.016
Female 88 (69) 978 (58)
Male 40 (31) 712 (42)
Median age (IQR) (years) Age 60 (50–68) 53 (44–64) < 0.001
Age group (years) 0.001
19–44 15 (12) 439 (26)
45–64 68 (53) 831 (49)
Above 64 45 (35) 420 (25)
Residence 0.966
Rural 14 (11) 193 (12)
Peri-urban 33 (26) 422 (24)
Urban 81 (63) 1075 (64)
Education level 0.23
<=Primary Education 50 (39) 753 (45)
Secondary 53 (41) 574 (34)
Post-Secondary 25 (20) 363 (21)
Socioeconomic status 0.107
Lower 22 (17) 408 (24)
Middle 58 (45) 771 (46)
Upper 48 (38) 511 (30)
Life style characteristics
Smoking 0.19
No 119 (93) 1509 (89)
Yes 9 (7) 181 (11)
Alcohol 0.646
No 93 (73) 431 (26)
Yes 35 (27) 1259 (74)
DM treatment characteristics
Life style alone 0.176
No 127 (99) 1637 (97)
Yes 1 (1) 53 (3)
Lifestyle and monotherapy 0.03
No 106 (83) 1254 (74)
Yes 22 (17) 436 (26)
Lifestyle and dual therapy 0.006
No 40 (31) 740 (44)
Yes 88 (69) 950 (56)
Lifestyle and triple therapy 0.359
No 115 (90) 1557 (92)
Yes 13 (10) 133 (8)
Lifestyle and combination injection therapy 0.037
No 122 (95) 1514 (90)
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presence of neuropathy, low income, smoking and male
sex being associated to loss to follow up.
Study strengths
To our understanding, this study is one of the first
studies to evaluate diabetes care in a private not for
profit health facility in Uganda focusing on patients’
LTFU. Assessment of LTFU among patients with
diabetes mellitus is important as it is directly related
to attainment of optimal glyceamic control and pre-
vention of complications of diabetes. Secondly un-
derstanding factors associated with LTFU from care
can provide valuable information for the improve-
ment of care. The use of patients routine care data
for this review has provided us with a large sample
size which would not have been feasible if otherwise.
Study limitations
As with most clinic care records, the quality of data recorded
is usually less satisfactory, and in our case, the incomplete
data on referrals and deaths might have biased our estimated
LTFU. Additionally this data from an operational program
was initially not designed for research purposes, not vali-
dated, had no quality checks done for completeness and
plausibility, and we were only able to look at a limited num-
ber of variables documented in the patient’s charts. We also
have little understanding of the health system and patient re-
lated reasons for drop out of care which can only be
Table 1 Baseline characteristics of patients retained and LTFU in a retrospective chart review study of patients with type 2 diabetes
mellitus (Continued)
Variable Name Category Retained N (col %) 128 (7%) LTFU N (col %) 1690 (93%) Chi-Square P-value
Yes 6 (5) 176 (10)
DM complications and comorbidities
Neuropathy < 0.001
No 54 (42) 1141 (68
Yes 74 (58) 549 (32))
Nephropathy 0.005
No 114 (89) 1605 (95)
Yes 14 (11) 85 (5)
Retinopathy 0.01
No 94 (73) 1394 (82)
Yes 34 (27) 296 (18)
Macroangiopathy 0.003
No 120 (94) 1654 (98)
Yes 8 (6) 36 (2)
Diabetic foot 0.038
No 116 (91) 1604 (95)
Yes 12 (9) 86 (5)
Hypoglycaemia 0.095
No 122 (95) 1651 (98)
Yes 6 (5) 39 (2)
Hypertension 0.001
No 26 (20) 593 (35)
Yes 102 (80) 1097 (65)
Erectile dysfunctiona < 0.001
No 23 (57) 576 (81)
Yes 17 (43) 136 (19)
Fasting plasma glucose (Mmol/l) 0.955
Controlled glycaemia 35 (27) 466 (28)
Hyperglycaemia 93 (73) 1224 (72)
DM - Diabetes mellitus, aErectile dysfunction - (Not Applicable for 1066 females). Boldface means significant at P-value < 0.05 for Tables 1 & 2
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Table 2 Multivariable analysis of predictors of patients lost to follow-up
Variable Name Category LTFU
N = 1690
n (col%)
uHR 95%CI P-value aHR 95%CI P-value
Socio-demographic Characteristics
Sex
Female 712 (42) Reference
Male 978 (58) 1.27 (1.15–1.40) < 0.001 1.17 (1.06–1.30) 0.002
Age group
19–44 439 (26) Reference
45–64 831 (49) 0.73 (0.65–0.83) < 0.001 0.83 (0.74–0.94) 0.003
Above 64 420 (25) 0.63 (0.55–0.72) < 0.001 0.78 (0.67–0.90) 0.001
Socioeconomic statu
Lower 408 (24) Reference
Middle 771 (46) 0.88 (0.78–0.99) 0.041 0.83 (0.74–0.94) 0.003
Upper 511 (30) 0.88 (0.77–0.99) 0.046 0.83 (0.73–0.95) 0.006
Life Style Characterisitcs
Smoking
No 1509 (89) Reference
Yes 181 (11) 1.26 (1.08–1.47) 0.003 1.22 (1.04–1.44) 0.016
DM Treatment characteristics
Lifestyle and monotherapy
No 1254 (74) Reference
Yes 436 (26) 1.34 (1.20–1.49) < 0.001 1.02 (0.86–1.22) 0.808
Lifestyle & dual therapy
No 740 (44) Reference
Yes 950 (56) 0.81 (0.74–0.90) < 0.001 0.79 (0.67–0.94) 0.006
Lifestyle & triple therapy
No 1557 (92) Reference
Yes 133 (8) 0.79 (0.66–0.95) 0.01 0.77 (0.61–0.97) 0.028
DM Complications and comorbidities
Hypertension
No 593 (35) Reference
Yes 1097 (65) 0.71 (0.65–0.79) < 0.001 0.90 (0.81–1.01) 0.07
Neuropathy
No 1141 (68) Reference
Yes 549 (32) 0.64 (0.57–0.70) < 0.001 0.72 (0.65–0.81) < 0.001
Nephropathy
No 1605 (95) Reference
Yes 85 (5) 0.54 (0.43–0.67) < 0.001 0.57 (0.45–0.71) < 0.001
Retinopathy
No 1394 (82) Reference
Yes 296 (18) 0.70 (0.62–0.80) < 0.001 0.89 (0.78–1.02) 0.101
Macroangiopathy
No 1654 (98) Reference
Yes 36 (2) 0.75 (0.54–1.05) 0.093 0.91 (0.65–1.27) 0.579
Diabetic foot
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answered by a purposively designed qualitative study. Due to
the changes in the general economic status in the country,
the patients economic status might have changed over the
13 years duration of the study from what it was at registra-
tion in the clinic. Although rural to urban migration is com-
mon among those searching for jobs, urban to rural
migration also occurs among those who find urban employ-
ment and survival hard to obtain, which might have contrib-
uted to LTFU. The method used by the health facility to
classify socioeconomic status and residence were not stan-
dardised and could have changed over the years.
Conclusion
Loss to follow up in a diabetes mellitus care has serious
implications for patients with diabetes mellitus due to
the subsequent complications and resultant morbidity,
mortality and management costs as well as the disease
burden on the health system. Our findings war-
rant stengthening patient follow up in diabetes care and
conducting interventional studies targeting the identified
associated risk factors for LTFU.
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